ONECHAIN IMMUNOTHERAPEUTICS
OneChain Immunotherapeutics is a spin-off Company from Instituto de Investigación contra la Leucemia Josep Carreras and ICREA, that aims to develop CAR-T candidates against different antigens as a treatment for hematological malignancies based on the know-how of Dr. Pablo Menéndez.
ONECHAIN IMMUNOTHERAPEUTICS
Industry:
Biotechnology Life Science
Founded:
2020-01-01
Address:
Barcelona, Catalonia, Spain
Country:
Spain
Website Url:
http://www.onechaintx.com
Total Employee:
1+
Status:
Active
Total Funding:
3.05 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Global Site Tag Euro
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
ImmPACT Bio
ImmPACT Bio USA is developing novel cell therapies for treating cancer.
Current Employees Featured
Founder
Investors List
Invivo Capital Partners
Invivo Capital Partners investment in Seed Round - OneChain Immunotherapeutics
Josep Carreras Leukaemia Research Institute
Josep Carreras Leukaemia Research Institute investment in Seed Round - OneChain Immunotherapeutics
Catalan Institution for Research and Advanced Studies
Catalan Institution for Research and Advanced Studies investment in Seed Round - OneChain Immunotherapeutics
Official Site Inspections
http://www.onechaintx.com
- Host name: shx814.guebs.net
- IP address: 185.23.70.117
- Location: Spain
- Latitude: 40.4172
- Longitude: -3.684
- Timezone: Europe/Madrid
More informations about "OneChain Immunotherapeutics"
Board of directors - Onechaintx
Pablo Menéndez Founder and CSO. Pablo Menéndez was awarded a PhD by the University of Salamanca in 2002. He then conducted postdoctoral training (2002-2006) in stem cell biology …See details»
Team - OneChain
Cristina also has more than 15 years of experience in the Financial Sector, were she worked as Senior Management Executive Assistant and as Deputy Director and Account Manager of bank office. Cristina joined OneChain …See details»
OneChain Immunotherapeutics - Crunchbase Company Profile
OneChain Immunotherapeutics is a spin-off Company from Instituto de Investigación contra la Leucemia Josep Carreras and ICREA, that aims to develop CAR-T candidates against …See details»
OneChain Immunotherapeutics SL - Drug pipelines, Patents, …
Sign Up for Free. Last update 01 Nov 2024See details»
OneChain Immunotherapeutics Overview | SignalHire Company …
OneChain Immunotherapeutics is a spin-off Company from the Josep Carreras Leukemia Research Institute and ICREA, that aims to develop CAR-T candidates against different …See details»
OneChain - Wiki - Golden
OneChain is a spin-off company from the Josep Carreras Leukemia Research Institute and ICREA, that aims to develop immunotherapies against hematological neoplasms using CAR-T …See details»
OneChain Immunotherapeutics - Overview, News & Similar
View OneChain Immunotherapeutics (www.onechaintx.com) location in Spain , revenue, industry and description. Find related and similar companies as well as employees by title and much …See details»
OneChain Immunotherapeutics Company Information - Funding, …
OneChain Immunotherapeutics, based in Barcelona, specializes in developing CAR-T therapies for leukemia. This niche focus distinguishes them from traditional treatments like …See details»
:site_name - onechaintx.com
OC-1 CART CD1a Immunotherapy. T-ALL comprises 10–15% of all acute leukemias diagnosed in children and 20–25% in adults, with a median diagnostic age of 9 years.See details»
Onechain Immunotherapeutics - Company Profile - Tracxn
Nov 13, 2024 Onechain Immunotherapeutics ranks 188th among 311 active competitors. 122 of its competitors are funded while 76 have exited. Overall, Onechain Immunotherapeutics and …See details»
OneChain Immunotherapeutics SL (OneChain Immunotherapeutics …
First in humans, exploratory, open-label, single-arm, multicentre, non-competitive, dose escalation study to assess the safety and efficacy of CD1a-CAR T therapy in patients with …See details»
OneChain - EU-Startups
OneChain is a spin-off company from the Josep Carreras Leukemia Research Institute and ICREA, that aims to develop immunotherapies against hematological neoplasms using CAR-T …See details»
OneChain | Who we are
Onechain Immunotherapeutics is a clinical stage biotech company based in Barcelona (Spain) and focused in the development of CAR T therapies for the treatment of oncological diseases.See details»
NanoCell Therapeutics Inc. and OneChain Immunotherapeutics S.L …
May 16, 2024 NanoCell Therapeutics Inc. 150 N Radnor Chester Road Suite A210 Wayne PA 19087 United StatesSee details»
2024 – Nanocell Therapeutics
May 16, 2024 Wayne, PA – March 19, 2024 — NanoCell Therapeutics, Inc. (“NanoCell”), a company developing in-vivo cell engineering solutions based on its proprietary non-viral, DNA …See details»
OneChain | Whistleblowing Channel
Electronically: [email protected]. By mail to the following address: C/Baldiri Reixac, n.º 4-6, Edificio Torres R+D+I, Parc Científic de Barcelona, (08028) Barcelona – to the …See details»
Onechain - Crunchbase Company Profile & Funding
ONECHAIN is a global cryptocurrency exchange that provides Spot and Futures trading between Bitcoin (BTC), Ethereum (ETH), Tether (USDT), and other altcoins.See details»
May 2024 – Nanocell Therapeutics
May 16, 2024 NanoCell Therapeutics Inc. 150 N Radnor Chester Road Suite A210 Wayne PA 19087 United StatesSee details»
Pipeline - OneChain
T-ALL comprises 10–15% of all acute leukemias diagnosed in children and 20–25% in adults, with a median diagnostic age of 9 years. Survival of patients with T-ALL treated with intensive …See details»